# NGENLA
> **BLA761184** · Biologics License Application · Sponsor: PFIZER IRELAND PHARMACEUTICALS · Approved 2023-06-27
## Drug
- **FDA Application Number:** BLA761184
- **Application type:** Biologics License Application
- **Brand name:** NGENLA
- **Generic name:** SOMATROGON-GHLA
- **Active ingredients:** SOMATROGON-GHLA
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** PFIZER IRELAND PHARMACEUTICALS
- **Manufacturer:** Pfizer Laboratories Div Pfizer Inc
- **First approval:** 2023-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761184)
---
*AI Analytics · CC0 1.0*